The European Medicines Agency is hosting a symposium to explore themes such as the natural evolution of patients’ role from interested stakeholders to advisors and decision-makers, evidence-based methods of patient preference data collection. In addition, topics, such as collaborative research networks and registries for real-world data generation, also in difficult areas, including rare cancers and palliative care, will be discussed.